HOME > Investors > Press Releases
2017-07-07
VM202 to Begin Patient Enrollment for Diabetic/Ischemic Non-healing Foot Ulcer (NHU) Phase III Clinical Trial in US
2017-06-30
ViroMed to Present at Biotech Japan 2017 Keynote Session
2017-06-13
[Dong-A Business Review] ViroMed - 1st generation Bio-Venture in Korea and its growth strategy
2017-05-25
2017.05(IR letter) Business Updates
2017-04-04
2016 Annual Report
1 2 3 4 5 6 7 8 9 10